Skip to main content
OpenTrials
Completed

NCT Number: NCT05753709

Conventional Hand Sewn End-To-End Anastomosis Versus Side-To-Side Anastomosis for Stoma Reversal: A Prospective Study

The goal of this clinical trial is to compare approaches to enterostomy reversal by hand-sewn end-to-end anastomosis versus side-to-side anastomosis (sub-divided into hand-sewn side-to-side anastomosis and stapled side-to-side anastomosis). The main question it aims to answer is:

• If either of the approaches are better than the other with respect to success rates, efficacy, post-operative complications and overall morbidity.

Participants admitted for stoma reversal will be divided into two groups:

1. EE: Conventional Hand-sewn end-to-end anastomosis, and 2. SS: Side-to-side anastomosis, which will be further divided into 2 sub-groups:

1. HSSA: Hand-sewn side-to-side anastomosis 2. SSSA: Stapled side-to-side anastomosis

Researchers will compare the EE group to SS group overall, and a second comparison will be made between EE, HSSA and SSSA groups, to see:

1. Rates of major post-operative complications 2. Rates of short-term complications (within 30 days of surgery) 3. Rates of re-operation 4. Post-operative length of stay in the hospital

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Sawai Mansingh Medical College and Hospital

Jaipur, Rajasthan, 302004, India

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Eligible participants were all the patients admitted in general surgical wards of SMS Hospital, Jaipur, for stoma reversal, after taking written informed consent

Exclusion criteria

  • Pre-operatively diagnosed malnutrition or cachexia
  • Bleeding disorders
  • Patients undergoing stoma reversal along with a concurrent abdominal surgery
  • Rectal anastomosis
  • Use of circular stapler for anastomosis.

Treatment and study plan

Hand sewn end-to-end anastomosis

Procedure

Hand sewn end-to-end anastomosis (EE) Holding sutures were taken through a seromuscular bite with PDS (Polydiaxonone) 3-0 or Silk 2-0 RB (Round Bodied needle), one each at the mesenteric and antimesenteric ends of the stoma. A posterior layer of Lembert sutures was taken first. The first bite was taken at the anti-mesenteric end and a knot was applied. A Connell stitch was applied at the corner and then the posterior layer was closed using an inverting interlocking continuous stitch till the mesenteric end. Another Connell stitch was applied here to secure the corner and the suture was continued on to the anterior layer which was then closed in a similar manner using a continuous interlocking stitch. The final bite crossed the initial knot and the final knot was applied. An anterior layer of Lembert sutures was taken to reinforce the anastomotic line.

Hand sewn side-to-side anastomosis

Procedure

Hand sewn side-to-side anastomosis (HSSA) Each end of the stoma was closed using either a single layer of inverting interlocking continuous sutures with PDS 3-0 or Silk 2-0 RB, or a Linear Stapling device. The two closed stumps were then brought adjacent to each other in an anti-peristaltic arrangement. A posterior layer of Lembert sutures was applied using Silk 2-0 RB. The bowel wall was incised using electrocautery close to the suture line. The incision was lengthened up to a width of at least 5-6 cm. The posterior and anterior layer was now closed using the same technique as in HS using PDS 3-0. An anterior layer of Lembert sutures was applied. The mesenteric defect was then closed using a superficial interrupted layer of Silk 2-0 RB.

Stapled side-to-side anastomosis

Procedure

Stapled side-to-side anastomosis or Functional End-to-end anastomosis (SSSA/FEEA) The two limbs of a Linear Cutter SR55 are placed into the proximal and distal bowel loops of the stoma, facing as far away from the mesenteric border as possible and then fired. If both lumens are of similar size, traction sutures are applied with Silk 2-0 RB at the anterior and posterior termination ends of the staple line. The two ends are pulled away from each other, and a Linear Cutter SR75 is applied just below the edge of the bowel and fired. However, in case of an ileo-colostomy, after the first linear cutter SR55 is fired, the two suture lines are approximated in such a way that they do not get apposed but rather lie adjacent to each other. The lumen is then clamped in SR75 which is then fired.

Primary outcomes

  1. Number of participants with Post-operative Ileus (POI)

    Time frame: From the day of surgery for 30 days

    Number of participants with two or more episodes of nausea/vomiting, inability to tolerate oral diet over 24 hours, absence of flatus over 24 hours, or distension, and with radiologic confirmation, occurring postoperatively without spontaneous resolution

  2. Number of participants with Anastomotic Leak

    Time frame: From the day of surgery for 30 days

    Number of participants with leakage of bowel contents from the anastomotic site, confirmed with imaging studies and clinical signs, such as fever >38.5˚C, leucocytosis, elevated serum C-reactive protein, drainage of intestinal content from the drain or computed tomography findings of abscess formation around the anastomosis.

  3. Number of participants with complications of Clavien-Dindo grade higher than 2

    Time frame: From the day of surgery for 30 days

    Number of participants with complications developing post-operatively of Clavien-Dindo grade higher than 2, suggestive of a severe complication.

  4. Number of participants with Bowel Obstruction

    Time frame: From the day of surgery for 30 days

    Number of participants with Bowel dilatation and obstipation (inability to pass flatus as well as motion), requiring surgery for treatment, with transition point of the obstruction confirmed either radiologically or intraoperatively

Secondary outcomes

  1. Operating Time

    Time frame: Intraoperatively

    Time during surgery from incision to skin closure

  2. Number of participants with Wound Infection

    Time frame: From the day of surgery for 30 days

    Number of participants with Infection of the incision site ranging from simple local purulent collection to overt infection requiring re-operation

  3. Number of participants with Anastomotic Bleeding

    Time frame: From the day of surgery for 30 days

    Number of participants with Evidence of bleeding around the anastomotic site, confirmed by a complaint of melena, or radiological or endoscopic findings.

  4. Number of participants with Anastomotic Stricture

    Time frame: From the day of surgery for 30 days

    Number of participants with Imaging studies done in patients with complaints of nausea or bloating after oral intake, demonstrating intestinal distension starting from oral side of the anastomotic site, occurring due to narrowing at the site of anastomosis due to any cause. This did not include patients unable to pass flatus and motion (obstipation, criteria for bowel obstruction) or patients only unable to tolerate oral diet without other symptoms (criteria for POI).

  5. Number of participants with Intra-abdominal Collection

    Time frame: From the day of surgery for 30 days

    Number of participants with fluid collection inside the abdominal cavity developing post-operatively, of any origin, which was not present before surgery. The fluid collection includes presence of ascitic fluid, blood or pus, in amount sufficient to be detected by an abdominal ultrasound or computed tomography imaging. The number of participants showing presence of fluid was measured, and not the volume of fluid.

  6. Number of participants with Re-operation

    Time frame: From the day of surgery for 30 days

    Number of participants developing complications severe enough and not responding to medical management, that needed to be re-operated

  7. Number of participants with Organ Dysfunction for each individual organ

    Time frame: From the day of surgery for 30 days

    Number of participants with Dysfunction in any organ, evidenced by symptoms and blood tests, developing post-operatively and not present before surgery. The outcome was measured as the number of participants developing dysfunction of each a particular organ system, labelled as Renal, Cardiac, Hepatic, Vascular and Respiratory.

  8. Overall Morbidity

    Time frame: From the day of surgery for 30 days

    The overall morbidity is reflective of the number of patients who have at least 1 complication; that is, patients who have at least 1 complication were counted only once, and only their highest-grade complication was counted, graded on the Clavien-Dindo scale.

Other outcomes

  1. Days to Bowel Movement

    Time frame: From the day of surgery for 30 days

    number of days for patient to first pass flatus or first stool after surgery

  2. Days to Liquid diet

    Time frame: From the day of surgery for 30 days

    number of days for patient to be first started on and tolerate liquids given per-orally, without causing vomiting or abdominal distension

  3. Days to Solid diet

    Time frame: From the day of surgery for 30 days

    number of days for patient to be first started on and tolerate progressively increasing semi-solid diet given per-orally, without causing vomiting or abdominal distension

  4. Postoperative length of stay

    Time frame: From the day of surgery for 30 days

    Number of days for the patient to be discharged from the hospital without complications.

Sponsors and collaborators

Lead sponsor

Sawai Mansingh Medical College

Other Gov

Registry information

Official study title

Conventional Hand Sewn End-To-End Anastomosis Versus Side-To-Side Anastomosis for Stoma Reversal: A Randomised Clinical Trial

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Mar 3, 2023
Registry last updated
Mar 3, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.